Reversible anti-settlement activity against Amphibalanus (= Balanus ) amphitrite, Bugula neritina , and Hydroides elegans by a nontoxic pharmaceutical compound, mizolastine
KAUST Grant NumberKAUST005-CML.07/08
Online Publication Date2009-07-24
Print Publication Date2009-11
Permanent link to this recordhttp://hdl.handle.net/10754/599506
MetadataShow full item record
AbstractMizolastine, an antihistamine pharmaceutical, was found to significantly inhibit larval settlement of the barnacle Amphibalanus (=Balanus) amphitrite, the bryozoan Bugula neritina, and the polychaete Hydroides elegans with EC50 values of 4.2, 11.2, and 4.1 mg ml-1, respectively. No toxicity against the larvae of these three species was observed at the concentration range tested during incubations with mizolastine. To determine whether the anti-settlement activity of mizolastine is reversible, recovery bioassays using these three species were conducted. More than 70% of the larvae that had been exposed for 4 h to mizolastine at concentrations four-fold greater than their respective EC50 values completed normal metamorphosis. The results of the recovery bioassay provide evidence that the antisettlement effect of mizolastine is reversible in addition to being nontoxic. The anti-settlement activities of several intermediates of the synthesis process of mizolastine were also examined. One of the intermediates, 2-chloro-1-(4- fluorobenzyl)-1H-benzo[d]imidazole, inhibited larval settlement and metamorphosis with low toxicity. These results may improve the understanding of the key functional group responsible for the anti-settlement activity of mizolastine. © 2009 Taylor & Francis.
CitationZhou X, Xu Y, Jin C, Qian P-Y (2009) Reversible anti-settlement activity against Amphibalanus (= Balanus ) amphitrite, Bugula neritina , and Hydroides elegans by a nontoxic pharmaceutical compound, mizolastine . Biofouling 25: 739–747. Available: http://dx.doi.org/10.1080/08927010903154724.
SponsorsThis study was supported by a grant from the Chinese Ocean Mineral Resources Research and Development Association (COMAR06/07.SC02), and the CAS/SAFEA International Partnership Program for Creative Research Teams as well as a research fund from KAUST International Partnership Program (KAUST005-CML.07/08) to Qian P.-Y.
PublisherInforma UK Limited
CollectionsPublications Acknowledging KAUST Support
- Adrenoceptor compounds prevent the settlement of marine invertebrate larvae: Balanus amphitrite (Cirripedia), Bugula neritina (Bryozoa) and Hydroides elegans (Polychaeta).
- Authors: Dahms HU, Jin T, Qian PY
- Issue date: 2004 Dec
- The effect of butenolide on behavioral and morphological changes in two marine fouling species, the barnacle Balanus amphitrite and the bryozoan Bugula neritina.
- Authors: Zhang YF, Wang GC, Ying X, Sougrat R, Qian PY
- Issue date: 2011 May
- Flavone and isoflavone derivatives of terrestrial plants as larval settlement inhibitors of the barnacle Balanus amphitrite.
- Authors: Zhou X, Zhang Z, Xu Y, Jin C, He H, Hao X, Qian PY
- Issue date: 2009
- Antifouling activity of simple synthetic isocyanides against larvae of the barnacle Balanus amphitrite.
- Authors: Nogata Y, Kitano Y, Yoshimura E, Shinshima K, Sakaguchi I
- Issue date: 2004 Apr
- Coumarins from the Herb Cnidium monnieri and chemically modified derivatives as antifoulants against Balanus albicostatus and Bugula neritina larvae.
- Authors: Wang ZC, Feng DQ, Ke CH
- Issue date: 2013 Jan 9